Format
Sort by

Send to

Choose Destination

Search results

Items: 18

1.

Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in Finland.

Trotta L, Hautala T, Hämäläinen S, Syrjänen J, Viskari H, Almusa H, Lepisto M, Kaustio M, Porkka K, Palotie A, Seppänen M, Saarela J.

Eur J Hum Genet. 2016 Oct;24(10):1473-8. doi: 10.1038/ejhg.2016.37. Epub 2016 May 4.

PMID:
27142677
2.

Ligand Binding Mechanism in Steroid Receptors: From Conserved Plasticity to Differential Evolutionary Constraints.

Edman K, Hosseini A, Bjursell MK, Aagaard A, Wissler L, Gunnarsson A, Kaminski T, Köhler C, Bäckström S, Jensen TJ, Cavallin A, Karlsson U, Nilsson E, Lecina D, Takahashi R, Grebner C, Geschwindner S, Lepistö M, Hogner AC, Guallar V.

Structure. 2015 Dec 1;23(12):2280-90. doi: 10.1016/j.str.2015.09.012. Epub 2015 Oct 22.

PMID:
26602186
3.

mtDNA Mutagenesis Disrupts Pluripotent Stem Cell Function by Altering Redox Signaling.

Hämäläinen RH, Ahlqvist KJ, Ellonen P, Lepistö M, Logan A, Otonkoski T, Murphy MP, Suomalainen A.

Cell Rep. 2015 Jun 16;11(10):1614-24. doi: 10.1016/j.celrep.2015.05.009. Epub 2015 May 28.

4.

Identification of indole inhibitors of human hematopoietic prostaglandin D2 synthase (hH-PGDS).

Edfeldt F, Evenäs J, Lepistö M, Ward A, Petersen J, Wissler L, Rohman M, Sivars U, Svensson K, Perry M, Feierberg I, Zhou XH, Hansson T, Narjes F.

Bioorg Med Chem Lett. 2015 Jun 15;25(12):2496-500. doi: 10.1016/j.bmcl.2015.04.065. Epub 2015 Apr 28.

PMID:
25978964
5.

The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation.

Edman K, Ahlgren R, Bengtsson M, Bladh H, Bäckström S, Dahmén J, Henriksson K, Hillertz P, Hulikal V, Jerre A, Kinchin L, Kåse C, Lepistö M, Mile I, Nilsson S, Smailagic A, Taylor J, Tjörnebo A, Wissler L, Hansson T.

Bioorg Med Chem Lett. 2014 Jun 1;24(11):2571-7. doi: 10.1016/j.bmcl.2014.03.070. Epub 2014 Apr 2.

PMID:
24755427
6.

HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase.

Evenäs J, Edfeldt F, Lepistö M, Svitacheva N, Synnergren A, Lundquist B, Gränse M, Rönnholm A, Varga M, Wright J, Wei M, Yue S, Wang J, Li C, Li X, Chen G, Liao Y, Lv G, Tjörnebo A, Narjes F.

Bioorg Med Chem Lett. 2014 Mar 1;24(5):1315-21. doi: 10.1016/j.bmcl.2014.01.050. Epub 2014 Jan 28.

PMID:
24508129
7.

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

Pemovska T, Kontro M, Yadav B, Edgren H, Eldfors S, Szwajda A, Almusa H, Bespalov MM, Ellonen P, Elonen E, Gjertsen BT, Karjalainen R, Kulesskiy E, Lagström S, Lehto A, Lepistö M, Lundán T, Majumder MM, Marti JM, Mattila P, Murumägi A, Mustjoki S, Palva A, Parsons A, Pirttinen T, Rämet ME, Suvela M, Turunen L, Västrik I, Wolf M, Knowles J, Aittokallio T, Heckman CA, Porkka K, Kallioniemi O, Wennerberg K.

Cancer Discov. 2013 Dec;3(12):1416-29. doi: 10.1158/2159-8290.CD-13-0350. Epub 2013 Sep 20.

8.

Synthesis and functionalization of cyclic sulfonimidamides: a novel chiral heterocyclic carboxylic Acid bioisostere.

Pemberton N, Graden H, Evertsson E, Bratt E, Lepistö M, Johannesson P, Svensson PH.

ACS Med Chem Lett. 2012 May 30;3(7):574-8. doi: 10.1021/ml3000935. eCollection 2012 Jul 12.

9.

Somatic STAT3 mutations in large granular lymphocytic leukemia.

Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmäki H, Andersson EI, Lagström S, Clemente MJ, Olson T, Jalkanen SE, Majumder MM, Almusa H, Edgren H, Lepistö M, Mattila P, Guinta K, Koistinen P, Kuittinen T, Penttinen K, Parsons A, Knowles J, Saarela J, Wennerberg K, Kallioniemi O, Porkka K, Loughran TP Jr, Heckman CA, Maciejewski JP, Mustjoki S.

N Engl J Med. 2012 May 17;366(20):1905-13. doi: 10.1056/NEJMoa1114885.

10.

Comparison of solution-based exome capture methods for next generation sequencing.

Sulonen AM, Ellonen P, Almusa H, Lepistö M, Eldfors S, Hannula S, Miettinen T, Tyynismaa H, Salo P, Heckman C, Joensuu H, Raivio T, Suomalainen A, Saarela J.

Genome Biol. 2011 Sep 28;12(9):R94. doi: 10.1186/gb-2011-12-9-r94.

11.

Novel conserved hydrolase domain in the CLCA family of alleged calcium-activated chloride channels.

Pawłowski K, Lepistö M, Meinander N, Sivars U, Varga M, Wieslander E.

Proteins. 2006 May 15;63(3):424-39.

PMID:
16470849
12.

Developing a pressure ulcer risk assessment scale for patients in long-term care.

Lepisto M, Eriksson E, Hietanen H, Lepisto J, Lauri S.

Ostomy Wound Manage. 2006 Feb;52(2):34-46.

13.

Patients with pressure ulcers in Finnish hospitals.

Lepistö M, Eriksson E, Hietanen H, Asko-Seljavaara S.

Int J Nurs Pract. 2001 Aug;7(4):280-7.

PMID:
11811400
14.

Prevention of pressure ulcers in acute and long-term care facilities in Finland: results of a survey.

Lepistö M, Eriksson E, Hietanen H, Asko-Seljavaara S.

Ostomy Wound Manage. 2000 Jun;46(6):30-4, 36-8, 40-1.

PMID:
11029933
15.

Nocturnal body movements and hypoxemia in middle-aged females after lower abdominal surgery under general anesthesia: a study with the static-charge-sensitive bed (SCSB).

Tallila T, Polo O, Aantaa R, Lepistö M, Lahdenperä A, Scheinin H.

J Clin Monit Comput. 1998 May;14(4):239-44.

PMID:
9754612
16.

Patients' needs in hospital: nurses' and patients' views.

Lauri S, Lepistö M, Käppeli S.

J Adv Nurs. 1997 Feb;25(2):339-46.

PMID:
9044009
17.

Determination of the degree of derivatization of acryloylated polysaccharides by Fourier transform proton NMR spectroscopy.

Lepistö M, Artursson P, Edman P, Laakso T, Sjöholm I.

Anal Biochem. 1983 Aug;133(1):132-5.

PMID:
6638476
18.

Reliability of a vibration test in screening for predisposition to tenosynovitis.

Kuorinka I, Videman T, Lepistö M.

Eur J Appl Physiol Occup Physiol. 1981;47(4):365-76.

PMID:
7199439
Items per page

Supplemental Content

Loading ...
Write to the Help Desk